SOD1 and stroke disorder: Compared with the MCAO group, MCAO with liproxstatin-1 treatment significantly attenuated the decrease of SOD level and the increased MDA level in mice caused by stroke (SOD: 52.10 ± 8.70 vs 75.00 ± 11.97, MDA: 18.23 ± 2.02 vs 13.23 ± 2.62, p ≤ 0.05; n = 5, one-way ANOVA, Figures 3E,F).